首页 | 本学科首页   官方微博 | 高级检索  
检索        


Erstattungsf?higkeit neuartiger Arzneimitteltherapien
Authors:APF Ehlers  A Wenke
Institution:1. Ehlers, Ehlers & Partner, Rechtsanwaltssociet?t, Widenmayerstr. 29, 80538, M??nchen, Deutschland
Abstract:Medical progress poses a new financial challenge for the German statutory health insurance. In order to assure the stability of the German statutory health insurance all services have to be economical, but on the other hand the health care system allows access to new therapy in the ambulant and in-patient sector. This article describes in detail how new therapies are reimbursed.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号